StockData
OnKure Therapeutics, Inc. logo

OnKure Therapeutics, Inc. (OKUR) stock

OKURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$2.58−0.17 (-6.18%)

Close on Nov 17, 2026Market cap $104.48MP/E –Yield –

OnKure Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

OnKure Therapeutics's price to book ratio was 0.4× on Nov 11, 2026, against 0.5× a year earlier. Over the last 4 years it ranged from 0.1× to 2.3×, with a median of 0.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−0.0
2025Dec 31, 20250.5×−0.0
2024Jan 31, 20240.5×+0.0
2023Dec 29, 20230.5×−0.0
2022Dec 30, 20220.5×−0.8
2021Dec 31, 20211.3×–

More OnKure Therapeutics figures

See a number that looks wrong?